BFRI
BiofronteraยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BFRI Profile
Biofrontera Inc.
A biopharmaceutical company that develops and commercializes dermatological products
120 Presidential Way, Suite 330, Woburn, MA 01801
--
Biofrontera Inc., was incorporated in Delaware in March 2015. The company is a US-based biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of skin diseases, especially diseases that cause skin damage due primarily to sun exposure. The company's licensed products focus on the treatment of actinic keratosis, a skin lesion that sometimes leads to skin cancer. The company also sells a topical antibiotic for the treatment of impetigo, a bacterial skin infection.
